📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo. (2015)

First Author: Rossi M

Attributed to: Using a Designer Receptor Exclusively Activated by Designer Drug to define the role of short chain fatty acids in metabolic disease and inflammation funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1519430112

PubMed Identifier: 26598688

Publication URI: http://europepmc.org/abstract/MED/26598688

Type: Journal Article/Review

Volume: 112

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 49

ISSN: 0027-8424